Ethypharm Report issue

For profit Phase 3
Founded: Franceau France (1977)
Status: No NME R&D (1977)

Organization Overview

First Clinical Trial
2011
NCT01842893
First Marketed Drug
2010
buprenorphine
First NDA Approval
None
Last Known Activity
2015

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

ETHYPHARM | ETHYPHARM USA CORP

Active Ingredients

Marketed Drugs (3)

buprenorphine (2010)

esomeprazole (nexium) (2021)

naloxone (narcan) (2015)

Drugs in Phase 3 Trials (2)

baclofen (lioresal) (1 trial)

fentanyl (Innovar) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Alcoholism (Phase 3)

Breakthrough Pain (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 2
  • # of Trial APIs: 2